Department of Cardiothoracic Surgery, Department of Surgery, NYU Langone Health, New York, NY.
Division of Vascular and Endovascular Surgery, Department of Surgery, NYU Langone Health, New York, NY; Division of Vascular and Endovascular Surgery, Department of Surgery, Beth Israel Deaconess Medical Center, Boston, Mass.
J Vasc Surg. 2022 Apr;75(4):1152-1162.e6. doi: 10.1016/j.jvs.2021.10.028. Epub 2021 Nov 3.
Patients with prior infrarenal aortic intervention represent an increasing demographic of patients undergoing thoracic endovascular aortic repair (TEVAR) and/or complex EVAR. Studies have suggested that prior abdominal aortic surgery is a risk factor for spinal cord ischemia (SCI). However, these results were largely based on single-center experiences with limited multi-institutional and national data that had assessed the clinical outcomes for these patients. The objective of the present study was to evaluate the effect of prior infrarenal aortic surgery on the occurrence of SCI.
The Society for Vascular Surgery Vascular Quality Initiative database was retrospectively reviewed to identify all patients aged ≥18 years who had undergone TEVAR and/or complex EVAR from January 2012 to June 2020. Patients with previous thoracic or suprarenal aortic repair were excluded. The baseline and procedural characteristics and postoperative outcomes were compared between TEVAR and/or complex EVAR with and without previous infrarenal aortic repair. The primary outcome was postoperative SCI. The secondary outcomes included postoperative hospital length of stay, bowel ischemia, renal ischemia, and 30-day mortality. Multivariate regression was used to determine the independent predictors of postoperative SCI. Additional analysis was performed of the patients who had undergone isolated TEVAR.
A total of 9506 patients met the inclusion criteria: 8691 (91.4%) had not undergone prior infrarenal aortic repair and 815 (8.6%) had undergone previous infrarenal aortic repair. Patients with previous infrarenal repair were older with an increased prevalence of chronic kidney disease (P = .001) and cardiovascular risk factors, including hypertension, chronic obstructive pulmonary disease, and positive smoking history (P < .001). These patients also presented with a larger maximal aortic diameter (6.06 ± 1.47 cm vs 5.15 ± 1.76 cm; P < .001) and required more stent-grafts (P < .001) with increased intraoperative blood transfusion requirements (P < .001), and longer procedure times (P < .001). Univariate analysis demonstrated no differences in postoperative SCI, postoperative hospital length of stay, bowel ischemia, or renal ischemia between the two groups. The 30-day mortality was significantly higher in patients with prior infrarenal repair (P = .001). On multivariate regression, prior infrarenal aortic repair was not a predictor of postoperative SCI. In contrast, aortic dissection (odds ratio [OR], 1.65; 95% confidence interval [CI], 1.26-2.16; P < .001), number of stent-grafts deployed (OR, 1.45; 95% CI, 1.30-1.62; P < .001), and units of packed red blood cells transfused intraoperatively (OR, 1.33; 95% CI, 1.03-1.73; P = .032) were independent predictors of postoperative SCI.
Although the patients in the TEVAR and/or complex EVAR group with prior infrarenal aortic repair constituted a sicker cohort with higher 30-day mortality, the rate of SCI was comparable to that of the patients without prior repair. Previous infrarenal repair was not associated with the risk of SCI.
在接受胸主动脉腔内修复术(TEVAR)和/或复杂型血管内修复术(EVAR)的患者中,既往有腹主动脉下段干预的患者代表了一个不断增加的人群。研究表明,既往腹部主动脉手术是脊髓缺血(SCI)的一个危险因素。然而,这些结果主要基于单中心经验,有限的多机构和国家数据评估了这些患者的临床结局。本研究的目的是评估既往腹主动脉下段手术对 SCI 发生的影响。
回顾性分析了 2012 年 1 月至 2020 年 6 月期间所有年龄≥18 岁、接受 TEVAR 和/或复杂型 EVAR 的患者的血管外科协会血管质量倡议数据库,排除既往有胸主动脉或肾上段主动脉修复的患者。比较 TEVAR 和/或复杂 EVAR 伴或不伴既往腹主动脉下段修复的患者的基线和手术特征及术后结局。主要结局为术后 SCI。次要结局包括术后住院时间、肠缺血、肾缺血和 30 天死亡率。多变量回归用于确定术后 SCI 的独立预测因素。对接受单纯 TEVAR 的患者进行了额外的分析。
共纳入 9506 例患者,符合纳入标准:8691 例(91.4%)未行既往腹主动脉下段修复,815 例(8.6%)行既往腹主动脉下段修复。既往有腹主动脉下段修复的患者年龄较大,慢性肾脏病的患病率更高(P=0.001),且合并心血管风险因素,包括高血压、慢性阻塞性肺疾病和阳性吸烟史(P<0.001)。这些患者的最大主动脉直径也更大(6.06±1.47cm vs. 5.15±1.76cm;P<0.001),需要更多的支架移植物(P<0.001),术中输血需求增加(P<0.001),手术时间延长(P<0.001)。单因素分析显示,两组间术后 SCI、术后住院时间、肠缺血或肾缺血无差异。既往腹主动脉下段修复组 30 天死亡率明显更高(P=0.001)。多变量回归分析显示,既往腹主动脉下段修复不是术后 SCI 的预测因素。相反,主动脉夹层(比值比[OR],1.65;95%置信区间[CI],1.26-2.16;P<0.001)、支架移植物的数量(OR,1.45;95%CI,1.30-1.62;P<0.001)和术中输注的单位浓缩红细胞(OR,1.33;95%CI,1.03-1.73;P=0.032)是术后 SCI 的独立预测因素。
尽管 TEVAR 和/或复杂 EVAR 组中既往有腹主动脉下段干预的患者构成了一个死亡率更高的更严重亚组,但 SCI 发生率与无既往修复的患者相当。既往腹主动脉下段修复与 SCI 的风险无关。